Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc down on Friday (RX)

Automated Summaries - The Globe and Mail - Fri Apr 5, 4:02PM CDT

Today, shares of Biosyent Inc opened at $8.63 and closed at $8.62. It traded at a low of $8.58 to a high of $8.65.

Share prices eased -0.35% from the previous day's close of $8.65.

Today across North America, the TSX Composite closed -0.27% at 22051.79, the S&P 500 closed -1.23% at 5147.21, the Dow Jones Industrial Average closed -1.35% at 38596.98 and the Nasdaq Composite closed -1.40% at 16049.08.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

A total of 4,007 shares was traded during the session, with total trades of 18, while having an average volume of 4,800 over 5 days.

Trading across the entire TSX-V saw 2,800 price advancers against 2,386 declines and 147 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 12 months, Biosyent Inc's shares have advanced 15.55%, while this year, they have eased -6.51%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.48 million on a float of 11,616 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc's average recommendation is "Moderate Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe